Showing results (411-420 of 448) with videos related to
Sort By:
Pageof 45
Atherosclerosis|April 9, 2019
Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-studyToralph Ruge, Axel C Carlsson, Erik Kjøller, et al.Journal of the American Heart Association|April 25, 2018
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial SubstudyAxel C Carlsson, Toralph Ruge, Erik Kjøller, et al.Atherosclerosis|September 28, 2018
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-studyJonas Wuopio, Jørgen Hilden, Carl Bring, et al.Molecular & Cellular Proteomics : MCP|November 13, 2014
Glycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modificationsAdnan Halim, Michael C Carlsson, Caroline Benedicte Madsen, et al.Journal of Nephrology|December 1, 2018
Circulating proteins as predictors of cardiovascular mortality in end-stage renal diseaseTobias Feldreich, Christoph Nowak, Tove Fall, et al.The Journal of Biological Chemistry|September 3, 2010
Mutational tuning of galectin-3 specificity and biological functionEmma Salomonsson, Michael C Carlsson, Veronica Osla, et al.Preventive Medicine Reports|September 12, 2019
An evidence-based toolbox for the design and implementation of selective-prevention primary-care initiatives targeting cardio-metabolic diseaseAnders Larrabee Sonderlund, Trine Thilsing, Joke Korevaar, et al.European Journal of Preventive Cardiology|June 20, 2018
Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: A systematic reviewAnne-Karien M de Waard, Per E Wändell, Martin J Holzmann, et al.Journal of Clinical Medicine|January 23, 2020
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-StudyErik Nilsson, Jens Kastrup, Ahmad Sajadieh, et al.Journal of the American College of Cardiology|August 26, 2017
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic MutationsEvan A Stein, Eldad J Dann, Albert Wiegman, et al.Pageof 45